Mc Elhenny Sheffield Capital Management, LLC Abb Vie Inc. Transaction History
Mc Elhenny Sheffield Capital Management, LLC
- $264 Million
- Q1 2025
A detailed history of Mc Elhenny Sheffield Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Elhenny Sheffield Capital Management, LLC holds 2,263 shares of ABBV stock, worth $419,899. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,263
Previous 2,269
0.26%
Holding current value
$419,899
Previous $403,000
17.62%
% of portfolio
0.18%
Previous 0.14%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,270Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.3 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.8 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.2 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.64 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $328B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...